Daniel Poor
Emergency Medicine · Memphis, TNNPI 1316352099
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,575 of the $3,085 with a category attached, or 83.5%. AstraZeneca accounts for 86.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $1,797 and has fallen 98.3% since, to $31 in 2024. Among emergency medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $85.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Johnson & Johnson$161
- CSL Behring$69
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$49
- Pfizer$44
- E.r. Squibb & Sons, L.L.C.$43
- plus $48 from 3 others
What the payments were for
- Speaking & faculty fees$2,57583%
- Food & beverage$51017%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $2,671 |
| Johnson & Johnson | 12 | $161 |
| CSL Behring | 3 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Pfizer | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Biosense Webster, Inc. | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Octapharma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$2,575
How this compares
$3,085 in reported general payments places this provider in the 95th percentile of 976 emergency medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 16 | $177 |
| Methylprednisolone | 21 | $160 |
| Cephalexin | 17 | $139 |
| Azithromycin | 18 | $62 |
| Naproxen | 12 | $38 |
| Prednisone | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Memphis
- Michael WashingtonMemphis$886
- Rose EllenMemphis$782
- Katrina HuttonMemphis$726
- Jeffrey AtkinsPikeville$140K
- Sean CollinsNashville$124K
- Wesley SelfNashville$35K
- Allison BollingerNashville$28K
- Adewale OdukoyaJackson$21K
- Jessica WhittleChattanooga$18K
- Mark ReiterNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.